Onkologie. 2008:2(2):82-84

Intensity-modulated radiotherapy in the treatment of head and neck cancer

Milan Vošmik
Klinika onkologie a radioterapie FN a LF UK Hradec Králové

Intensity-modulated radiotherapy (IMRT) is a novel radiotherapeutic method in the treatment of head and neck tumors that allows better sparing of healthy tissues and organs in this region. A new possibility of parotid salivary glands sparing offers an improvement of quality of life due to reduction of late xerostomia. The advantage of IMRT is also a possibility of dose escalation in some subvolumes of planning target volume (simultaneous integrated boost; SIB), e. g. in gross tumor volume. Non-randomized clinical series have shown promising results in tumor local control. The IMRT optimal treatment regimen for head and neck cancer has not been found yet.

Keywords: intensity-modulated radiotherapy, head and neck cancer

Published: August 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vošmik M. Intensity-modulated radiotherapy in the treatment of head and neck cancer. Onkologie. 2008;2(2):82-84.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Braam PM, Terhaard CH, Roesink JM et al. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66: 975-980. Go to original source... Go to PubMed...
    2. Pow EH, Kwong DL, McMillan AS et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006; 66: 981-991. Go to original source... Go to PubMed...
    3. Lee N, Xia P, Quivey JM et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002; 53: 12-22. Go to original source... Go to PubMed...
    4. Claus F, Boterberg T, Ost P, De Neve W. Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome? Radiother Oncol. 2002; 64: 205-208. Go to original source... Go to PubMed...
    5. Fua TF, Corry J, Milner AD, Cramb J, Walsham SF, Peters LJ. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia. Int J Radiat Oncol Biol Phys. 2007; 67: 976-981. Go to original source... Go to PubMed...
    6. Butler EB, Teh BS, Grant WH 3rd et al. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 1999; 45: 21-32. Go to original source... Go to PubMed...
    7. Wu Q, Manning M, Schmidt-Ullrich R et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys 2000; 46: 195-205. Go to original source... Go to PubMed...
    8. Lauve A, Morris M, Schmidt-Ullrich R et al. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II-clinical results. Int J Radiat Oncol Biol Phys 2004; 60: 374-387. Go to original source... Go to PubMed...
    9. Lee N, Xia P, Fischbein NJ et al. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 2003; 57: 49-60. Go to original source... Go to PubMed...
    10. Eisbruch A, Harris J, Garden A et al. Phase II multi-institutional study of IMRT for oropharyngeal cancer (RTOG 00-22): Early results. Int J Radiat Oncol Biol Phys 2006; 66(Suppl.): S46-S47. Go to original source...
    11. Kam MK, Teo PM, Chau RM et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2004; 60: 1440-1450. Go to original source... Go to PubMed...
    12. Lee NY, de Arruda FF, Puri DR et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2006; 66: 966-974. Go to original source... Go to PubMed...
    13. Lee NY, O'Meara W, Chan K et al. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys. 2007; 69: 459-468. Go to original source... Go to PubMed...
    14. Grégoire V, Levendag P, Ang KK et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003; 69: 227-236. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.